|
2401
|
AT 1001
|
High affinity and selective α3β4 nAChR ligand with partial agonistic and antagonistic effects |
€95.00 |
|
2462
|
BMH 21
|
Inhibitor of RNA Polymerase I (RNAP1) |
€95.00 |
|
2458
|
Clemizole
|
Inhibitor of the transient receptor potential channel TRPC5 |
€75.00 |
|
2390
|
HAMNO
|
Novel protein interaction inhibitor of replication protein A (RPA) |
€85.00 |
|
2446
|
Ispinesib
|
First potent, highly specific small-molecule inhibitor of human KSP |
€110.00 |
|
2464
|
LY 2584702 tosylate
|
Oral, selective ATP-competitive inhibitor of p70 S6 kinase (S6K1) |
€125.00 |
|
2321
|
ML 154
|
Competitive, selective, and brain penetrant NPS receptor antagonist |
€120.00 |
|
2415
|
Naloxone hydrochloride
|
Neutral opioid antagonist |
€50.00 |
|
2416
|
Naltrexone hydrochloride
|
Competitive opioid antagonist with preference for µ- and κ-receptors |
€45.00 |
|
2459
|
PND 1186
|
Orally active dual FAK/PYK2 inhibitor triggering cell apoptosis in tumor cells |
€105.00 |
|
2463
|
TBPB
|
Allosteric activator of the M1 acetylcholine receptor devoid of M2-M5 activity. |
€105.00 |
|
2452
|
VE 822
|
Selective ATR inhibitor that decreases survival of pancreatic cancer cells |
€110.00 |